A study by Dovedi et al. showed that fractionated radiotherapy caused PD-L1 upregulation on tumor cells in mouse models and combination of PD1/PD-L1 inhibitors with radiotherapy generated efficacious CD8 T-cell responses and better tumor control rate 75. The gene discussed is CD8A; the disease is neoplasm.